CAPITAL STOCK (Detail Textuals 1) - USD ($)		1 Months Ended				3 Months Ended	9 Months Ended
	Apr. 01, 2015	Apr. 30, 2015	Dec. 30, 2014	Dec. 19, 2014	Nov. 20, 2014	Jun. 30, 2015	Jun. 30, 2015	Jun. 30, 2014	Nov. 11, 2014
Stockholders' Equity Note [Abstract]
Underwritten public offering of common stock and warrants closed					2,800,000
Number of common stock called by warrants					2,800,000
Gross proceeds from underwritten public offering of common stock and warrants					$ 9,100,000
Gross proceeds to repurchase remaining Series B Warrants					$ 4,091,000
Conversion price of convertible promissory note converted into common stock (in dollars per share)					$ 3.25				$ 3.25
Period of warrant exercised					5 years
Exercise price of warrants					$ 3.50
Number of days option given to underwriters					45 days
Additional common stock purchase limit given to underwriters					420,000
Additional common stock per share purchase limit given to underwriters					$ 3.24
Additional warrants purchase limit given to underwriters					420,000
Additional per share warrants purchase limit given to underwriters					$ 0.01
Number of warrants for which underwriters' close exercise of its over-allotment option				416,850
Gross proceeds from closed on underwriters exercise of over-allotment option				$ 4,169
Common stock closed on underwriters additional exercise of over-allotment option			52,000
Gross proceeds from closed on underwriters additional exercise of over-allotment option			$ 168,400
Number of common stock including the exercise of over allotment option					2,852,000
Number of warrant issued including the exercise of over allotment option					3,216,850
Gross proceeds from sale of common stock and warrants					$ 9,272,649
Gross proceeds from underwritten public offering of common stock and warrants	$ 12,000,000	$ 263,950			9,300,000
Net proceeds from sale of common stock and warrants					$ 3,690,000		$ 19,114,418	$ 2,145,956
Additional number of common stock called by warrants					128,800
Exercise price of warrants which company agreed to issue to the underwriters					$ 3.73
Exercise price percentage of public offering price					115.00%
Number of common stock shares granted to consultant						15,000	22,500
Total expenses to consultant						$ 47,750	$ 64,426